Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS)

Centonze, C; Guzzetti, C; Orlando, G; Loche, S; Angeletti, C; Antoniazzi, F; Bernasconi, S; Cardinale, GM; Caruso-Nicoletti, M; Cavallo, L; Cianfarani, S; Citro, G; De Luca, F; Della Casa, S; Di Pietro, M; Garofalo, P; Giordano, C; Greggio, NA; Licenziati, MR; Maghnie, M; Parpagnoli, M; Persani, L; Pesce, S; Sacco, M; Salerno, M; Tafi, L

doi:10.1007/s40618-019-01046-1

Background: With the use of non-objective measurement, adherence to growth hormone (GH) therapy has been reported suboptimal in a large proportion of patients, and poor adherence has been shown to affect short-term growth response in patients receiving GH treatment. Objective: The Easypod™ electronic device allows objective measurement of adherence. In this study, we report 3-year prospective adherence data of the Italian cohort of naïve GH deficient (GHD) children extrapolated from the Easypod Connect Observational Study (ECOS) database. Patients and methods: Seventy-three GHD children naïve to GH treatment were included in the analysis. 22 Italian centers participated in the study. Results: Mean adherence rate was consistently above 85% across the 3-year observation period. Particularly, mean adherence was 88.5%, 86.6%, and 85.7% after 1, 2 and 3 years, respectively. Mean (± SD) height-SDS increase after the first year was 0.41 (± 0.38). Conclusions: The majority of naïve GHD children starting GH treatment with Easypod maintained an adherence rate > 85% up to 3 years. Easypod is a useful tool to follow-up patients’ adherence allowing timely intervention to improve optimal treatment for these patients.

Centonze C., Guzzetti C., Orlando G., Loche S., Angeletti C., Antoniazzi F., et al. (2019). Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS). JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION [10.1007/s40618-019-01046-1].

Data di pubblicazione:	2019
Titolo:	Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS)
Autori:	Centonze C. Guzzetti C. Orlando G. Loche S. Angeletti C. Antoniazzi F. Bernasconi S. Cardinale G. M. Caruso-Nicoletti M. Cavallo L. Cianfarani S. Citro G. De Luca F. Della Casa S. Di Pietro M. Garofalo P. GIORDANO, Carla [Membro del Collaboration Group] Greggio N. A. Licenziati M. R. Maghnie M. Parpagnoli M. Persani L. Pesce S. Sacco M. Salerno M. Tafi L. mostra contributor esterni nascondi contributor esterni
Citazione:	Centonze C., Guzzetti C., Orlando G., Loche S., Angeletti C., Antoniazzi F., et al. (2019). Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS). JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION [10.1007/s40618-019-01046-1].
Rivista:	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Digital Object Identifier (DOI):	http://dx.doi.org/10.1007/s40618-019-01046-1
Abstract:	Background: With the use of non-objective measurement, adherence to growth hormone (GH) therapy has been reported suboptimal in a large proportion of patients, and poor adherence has been shown to affect short-term growth response in patients receiving GH treatment. Objective: The Easypod™ electronic device allows objective measurement of adherence. In this study, we report 3-year prospective adherence data of the Italian cohort of naïve GH deficient (GHD) children extrapolated from the Easypod Connect Observational Study (ECOS) database. Patients and methods: Seventy-three GHD children naïve to GH treatment were included in the analysis. 22 Italian centers participated in the study. Results: Mean adherence rate was consistently above 85% across the 3-year observation period. Particularly, mean adherence was 88.5%, 86.6%, and 85.7% after 1, 2 and 3 years, respectively. Mean (± SD) height-SDS increase after the first year was 0.41 (± 0.38). Conclusions: The majority of naïve GHD children starting GH treatment with Easypod maintained an adherence rate > 85% up to 3 years. Easypod is a useful tool to follow-up patients’ adherence allowing timely intervention to improve optimal treatment for these patients.
URL:	http://link.springer.com/journal/40618
Appare nelle tipologie:	1.01 Articolo in rivista

File in questo prodotto:

File	Descrizione	Tipologia	Licenza
Centonze2019_Article_AdherenceToGrowthHormoneGHTher.pdf		Versione Editoriale		Administrator Richiedi una copia

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/10447/402221

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

File in questo prodotto: